http://www.biocryst.com
BioCryst Pharmaceuticals, Inc. Company Intro
BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).
Industry
Healthcare
BioCryst Pharmaceuticals, Inc. Headquaters
4505 Emperor Boulevard
Durham,27703
United States
BioCryst Pharmaceuticals, Inc. Share price
17 May 2023 12:51 GMT
$8.55
-0.22 (-2.51 %)
BioCryst Pharmaceuticals, Inc. Market cap
$1.598 B
WMC RANKING
2023
BioCryst Pharmaceuticals, Inc. # 132
BiotechnologyLatest BioCryst Pharmaceuticals, Inc. News
03 Oct 2023
Traders Purchase Large Volume of BioCryst Pharmaceuticals ...
BioCryst Pharmaceuticals, Inc, a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an...
02 Oct 2023
Notable Monday Option Activity: EXPE, FWRD, BCRX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Expedia Group Inc (Symbol: EXPE), where a total...
02 Oct 2023
World Smallpox Treatment Market Report 2023-2030: Antiviral ...
BioCryst Pharmaceuticals, Inc. Bharat Biotech International Ltd. Takeda Pharmaceutical Company Limited. Global Smallpox Treatment Market - Impact of Coronavirus...
WMC Market Score
WMC Market to Revenue Score
BioCryst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioCryst Pharmaceuticals, Inc. | USD | $32,048 | $209,674 | $-209,499 | $15,980B | 132 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BioCryst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| BioCryst Pharmaceuticals, Inc. | 0.51 | 4.68 | 0.01 | 0 | 0 | 0 | 2.34 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 0 | 0 | 0 | 2.53 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
